Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 179 publications

Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis.

Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis.

Journal: Tumori
Published: August 29, 2025

Association of HTR1F with Prognosis, Tumor Immune Microenvironment, and Drug Sensitivity in Cancer: A Multi-Omics Perspective.

Association of HTR1F with Prognosis, Tumor Immune Microenvironment, and Drug Sensitivity in Cancer: A Multi-Omics Perspective.

Journal: Biomedicines
Published: July 17, 2025

Correction to: Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.

Correction to: Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.

Journal: Current oncology reports
Published: May 09, 2025

FAHD1-mediated pyruvate metabolism in hepatocellular carcinoma: Multi-omics and causal genetic evidence.

FAHD1-mediated pyruvate metabolism in hepatocellular carcinoma: Multi-omics and causal genetic evidence.

Journal: HGG advances
Published: April 24, 2025

Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol.

Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol.

Journal: Acta oncologica (Stockholm, Sweden)
Published: April 23, 2025

Discovery of Genomic Targets and Therapeutic Candidates for Liver Cancer Using Single-Cell RNA Sequencing and Molecular Docking.

Discovery of Genomic Targets and Therapeutic Candidates for Liver Cancer Using Single-Cell RNA Sequencing and Molecular Docking.

Journal: Biology
Published: January 21, 2025

Receptor tyrosine kinase inhibitor tivozanib regulates cell state plasticity and restores MITF dependency in BRAF wild-type melanoma.

Receptor tyrosine kinase inhibitor tivozanib regulates cell state plasticity and restores MITF dependency in BRAF wild-type melanoma.

Journal: Acta pharmacologica Sinica
Published: January 14, 2025

Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors.

Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors.

Journal: Journal of pain and symptom management
Published: January 04, 2025

Novel Presentation of Lichenoid Dermatoses Preceding Bullous Pemphigoid Secondary to Immune Checkpoint Inhibitor Therapy.

Novel Presentation of Lichenoid Dermatoses Preceding Bullous Pemphigoid Secondary to Immune Checkpoint Inhibitor Therapy.

Journal: Skinmed
Published: January 03, 2025

Tivozanib monotherapy outperforms combination therapy in post-ICI RCC.

Tivozanib monotherapy outperforms combination therapy in post-ICI RCC.

Journal: Nature reviews. Urology
Published: November 11, 2024

Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.

Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.

Journal: Current oncology reports
Published: October 05, 2024

Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study.

Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study.

Journal: The oncologist
Published: September 15, 2024
Showing 1-12 of 179

Last Updated: 10/31/2025